AJLightning
09-14-2007, 12:47 AM
Monday and Tuesday of next week.
Here's a few I like...more to come over the weekend
(my opinion here...do your own research):p
1864
With DURECT expected to report Phase III results for Remoxy in 3Q07 and Phase II results for POSIDUR, ELADUR, and TRANSDUR Sufentanil in 4Q07, DURECT is approaching what is likely to be an exciting 2H07.
1865
I know this looks bad...but good news may be what they need for a good pop
1866
GenVec combines its patented gene transfer technologies with proprietary therapeutic genes to create product candidates such as TNFerade™, currently in a Phase II/III pivotal trial for locally advanced pancreatic cancer and multiple trials for additional solid tumor indications
1867
Here's a few I like...more to come over the weekend
(my opinion here...do your own research):p
1864
With DURECT expected to report Phase III results for Remoxy in 3Q07 and Phase II results for POSIDUR, ELADUR, and TRANSDUR Sufentanil in 4Q07, DURECT is approaching what is likely to be an exciting 2H07.
1865
I know this looks bad...but good news may be what they need for a good pop
1866
GenVec combines its patented gene transfer technologies with proprietary therapeutic genes to create product candidates such as TNFerade™, currently in a Phase II/III pivotal trial for locally advanced pancreatic cancer and multiple trials for additional solid tumor indications
1867